Biopharmaceutical company Menlo Therapeutics has appointed Ronald Krasnow as general counsel and chief compliance officer.

In this role, Krasnow will be responsible for all legal needs of the company, including intellectual property portfolio development and supporting the company’s commercial, clinical, regulatory, manufacturing, and development functions to ensure compliance with all applicable laws, rules, and regulations.

Most recently, Krasnow served as general counsel, chief strategy officer, and secretary at Kinestral Technologies, a company focused on bringing cutting-edge technology to the home and commercial construction markets. Prior to Kinestral, he spent approximately 10 years as general counsel at Relypsa, overseeing legal activities as the biotech company grew from a startup through its IPO, commercialization of its drug, and its acquisition by Galenica.